Portal for patients

Healthcare Industry News

About everything that happens with the clinics, medical and diagnostic centers, laboratories, pharmacies and cosmetic companies , as well as any other medical institutions of the country and the world. 

Two Vaccines Against Ebola Have Successfully Passed Safety Test
The experimental vaccines against Ebola developed by GlaxoSmithKline and NewLink Genetics have been recognized as being safe by the results of…
​Sun Pharmaceutical Bought Ranbaxy
Indian generics manufacturer Sun Pharmaceutical announced the closing of its acquisition of Ranbaxy for $ 3.2 billion.Absorption Ranbaxy will…
​Actavis Completed The Acquisition Of Allergan
Actavis finished its acquisition of Allergan worth $70.5 billion. According to experts, the estimated annual revenue of the combined company…
​Valeant Has Increased The Cost Of Salix Acquisition
Valeant increased the cost of the offer for the acquisition of Salix Pharmaceuticals to 10.96 billion dollars. Earlier, the Canadian company…
​Bristol-Myers Squibb Will Localize The Production Of Antitumor Dasatinib In Russia
Bristol-Myers Squibb and the group of "R-Pharm" companies signed a license agreement regarding the localization of production anticancer drug…
​Russian Scientists Are Testing A Unique Drug Against Alcoholism
"Odelepran", a new development of "R-Pharm", is being tested in Tomsk Research Institute of Mental Health. This medication is aimed at…
​Apple Introduced A New Research Platform ResearchKit
Apple introduced an open platform for data collection in medical research on March 9 during the presentation of new products. As stated by the…
​FDA Restricted Prescribing Testosterone
Food and Drug Administration (FDA) has demanded from the pharmaceutical manufacturers to make a warning that the use of testosterone…
​GlaxoSmithKline Is Preparing To Change The Chairman Of The Board Of Directors
Press office of GlaxoSmithKline announced the imminent departure of Christopher Gent from the position of Chairman of the Board of Directors.…
​Bristol-Myers Squibb announced the acquisition Flexus for $ 1.25 billion
Bristol-Myers Squibb agreed to buy all circulating shares of biotechnology company Flexus, specializing in the creation of innovative…
Application for treatment
Sex
MTEC 2019 (eng.-com)